122 related articles for article (PubMed ID: 6639001)
1. In vitro activity of midecamycin, a new macrolide antibiotic.
Neu HC
Antimicrob Agents Chemother; 1983 Sep; 24(3):443-4. PubMed ID: 6639001
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of RU 28965, a new macrolide, compared to that of erythromycin.
Rolston KV; LeBlanc B; Ho DH
J Antimicrob Chemother; 1986 Feb; 17(2):161-3. PubMed ID: 3700283
[TBL] [Abstract][Full Text] [Related]
3. In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria.
Barlam T; Neu HC
Antimicrob Agents Chemother; 1984 Apr; 25(4):529-31. PubMed ID: 6732223
[TBL] [Abstract][Full Text] [Related]
4. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].
Soussy CJ; Leclercq R; Duval J
Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331
[TBL] [Abstract][Full Text] [Related]
5. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
King A; Phillips I
Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
[TBL] [Abstract][Full Text] [Related]
6. Properties of midecamycin, a new macrolide antibiotic.
Salhi A; Vindel JA; Brunaud M; Berceaux G; Marin A; Wuatelet C
G Ital Chemioter; 1977; 24(1-2):67-76. PubMed ID: 308022
[No Abstract] [Full Text] [Related]
7. In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes.
Westerman EL; Williams TW; Moreland N
Antimicrob Agents Chemother; 1976 Jun; 9(6):988-93. PubMed ID: 7189
[TBL] [Abstract][Full Text] [Related]
8. In-vitro evaluation of miokamycin: bactericidal activity against streptococci.
Lacey RW; Lord VL; Howson GL
J Antimicrob Chemother; 1984 Jan; 13(1):5-13. PubMed ID: 6607918
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999.
Schlegel L; Merad B; Rostane H; Broc V; Bouvet A
Clin Microbiol Infect; 2001 Jul; 7(7):362-6. PubMed ID: 11531981
[TBL] [Abstract][Full Text] [Related]
10. Josamycin: interpretation of inhibition zones with the Bauer-Kirby agar disk diffusion test as compared with erythromycin.
Karthein J; Spohr M; Traub WH
Chemotherapy; 1986; 32(4):336-43. PubMed ID: 3731919
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae.
Jorgensen JH; Redding JS; Howell AW
Antimicrob Agents Chemother; 1986 May; 29(5):921-2. PubMed ID: 3488019
[TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of roxithromycin against hospital bacteria and the concordance curve].
Soussy CJ; Chanal M; Kitzis MD; Duval J; Cluzel R; Acar JF
Pathol Biol (Paris); 1988 May; 36(5):420-4. PubMed ID: 2900488
[TBL] [Abstract][Full Text] [Related]
13. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
Drabu YJ; Mehtar S; Blakemore PH
Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
[TBL] [Abstract][Full Text] [Related]
14. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs.
Jones RN; Barry AL; Thornsberry C
Antimicrob Agents Chemother; 1983 Aug; 24(2):209-15. PubMed ID: 6638988
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of common clinical anaerobic and aerobic isolates against josamycin.
Reese RE; Betts RF; Goedde LW; Douglas RG
Antimicrob Agents Chemother; 1976 Aug; 10(2):253-7. PubMed ID: 984766
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of A-56268 (TE-031), a new macrolide antibiotic, compared with that of erythromycin and other antimicrobial agents.
Floyd-Reising S; Hindler JA; Young LS
Antimicrob Agents Chemother; 1987 Apr; 31(4):640-2. PubMed ID: 2955742
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo antibacterial activity of 9,3"-Di-o-acetyl midecamycin (Mom), a new macrolide antibiotic.
Kawaharajo K; Sekizawa Y; Inoue M
J Antibiot (Tokyo); 1981 Apr; 34(4):436-42. PubMed ID: 6974163
[TBL] [Abstract][Full Text] [Related]
19. [Susceptibility of potential periodontopathic bacteria to metronidazole, spiramycin and their combination].
Mouton C; Dextraze L; Mayrand D
J Biol Buccale; 1984 Mar; 12(1):17-26. PubMed ID: 6584423
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin.
Barry AL; Thornsberry C; Jones RN
Antimicrob Agents Chemother; 1987 Feb; 31(2):343-5. PubMed ID: 2952064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
